GeneLink, Inc.
GNLKQ
$0.00
$0.000.00%
OTC PK
| 09/30/2013 | 06/30/2013 | 03/31/2013 | 12/31/2012 | 09/30/2012 | |
|---|---|---|---|---|---|
| Net Income | -65.89% | 8.11% | 64.94% | -3.56% | -1.23% |
| Total Depreciation and Amortization | -6.40% | -16.80% | -25.38% | 44.05% | -16.85% |
| Total Amortization of Deferred Charges | 2.17% | 2.44% | -62.72% | 180.70% | -12.60% |
| Total Other Non-Cash Items | -21.93% | 876.28% | -200.94% | -68.63% | -65.09% |
| Change in Net Operating Assets | 546.05% | -139.11% | 127.18% | -65.24% | 13.81% |
| Cash from Operations | 57.21% | -4.69% | 80.76% | -19.51% | -24.21% |
| Capital Expenditure | -- | -- | -- | 70.97% | 92.49% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -100.00% | 38.61% |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -105.63% | 158.22% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 33.33% | -- | -- | -- | 1,676.81% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 33.33% | -- | -- | -103.40% | 1,676.81% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,361.00% | 93.20% | 82.04% | -189.85% | 260.02% |